Systemic Treatment of Metastatic/Recurrent Uterine Leiomyosarcoma: A Changing Paradigm

The treatment of metastatic and recurrent uterine leoimyosarcoma (uLMS) has evolved rapidly in the past several years. Leoimyosarcoma is extremely aggressive and responds poorly to traditional chemotherapeutics. Recent regulatory approval of novel treatment options has significantly expanded the the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Principais autores: Arend, Rebecca C., Toboni, Michael D., Montgomery, Allison M., Burger, Robert A., Olawaiye, Alexander B., Monk, Bradley J., Herzog, Thomas J.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Inc. 2018
Assuntos:
Gynecologic Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6292548/
https://ncbi.nlm.nih.gov/pubmed/30139839
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0095
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados